[ET Net News Agency, 17 August 2021] CSPC PHARMA (01093) rose 4.84% to HK$11.7.
It hits an intra-day high of HK$11.74, hitting an 1-month high, and an intra-day low of
HK$11.14. The total shares traded was 12.84 million, with a value of HK$147.1m. The active
buy/sell ratio is 68:32, with net buying turnover of HK$48.07m. CITIGROUP GLOBAL accounts
for greatest net responsive buying turnover of HK$7.57m, with volume weighted average
price of HK$11.439. MERRILL LYNCH FE accounts for greatest net responsive selling turnover
of HK$11.16m, with volume weighted average price of HK$11.418. The stock has risen a
combined 7.34% over the past 2 consecutive trading days.
The Hang Seng Index now fell 9 points, or 0.03% to 26,172; the Hang Seng China
Enterprises Index now fell 16 points, or 0.17% to 9,249; the Hang Seng TECH Index now fell
71 points, or 1.11% to 6,348; with an overall turnover of HK$30.52b.
The SSE Composite Index now rose 5 points, or 0.15% to 3,522, with an overall turnover
of RMB168.77b.
The SZSE Component Index now fell 16 points, or 0.11% to 14,677, with an overall
turnover of RMB96.46b.
Basic Information
-------------------------------------------
Nominal 11.700 % Chg +4.84%
High 11.740 Low 11.140
Shares Tr 12.84m Turnover 147.1m
10-D SMA 10.942 %H.V 42.352
20-D SMA 10.691 VWAP 11.460
50-D SMA 11.040 RSI14 65.774
-------------------------------------------
Status: Hitting an 1-month high, active buy/sell ratio is 68:32, with net buying
turnover of HK$48.07m, rising a combined 7.34% over the past 2 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
CSPC PHARMA (01093) 11.70 +4.84
SIHUAN PHARM (00460) 2.48 -0.80
CMS (00867) 17.14 +1.78
SINO BIOPHARM (01177) 6.69 +1.36
3SBIO (01530) 7.75 +0.52
LUYE PHARMA (02186) 4.09 +0.49
FOSUN PHARMA (02196) 58.00 -0.09
WUXI APPTEC (02359) 155.40 -0.06
PHARMARON (03759) 166.70 +0.54
UNITED LAB (03933) 5.86 +9.12
-------------------------------------------------
(ed)